OpenURL Connection Search

Select item for more details and to access through your institution.

The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial.
Published in:
2016
By:
- Jamshidi, Neema;
- Jonasch, Eric;
- Zapala, Matthew;
- Korn, Ronald;
- Brooks, James;
- Ljungberg, Borje;
- Kuo, Michael;
- Korn, Ronald L;
- Brooks, James D;
- Kuo, Michael D
Publication type:
journal article
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
Published in:
Investigational New Drugs, 2019, v. 37, n. 4, p. 636, doi. 10.1007/s10637-018-0668-8
By:
- Babiker, Hani M.;
- Byron, Sara A.;
- Hendricks, William P. D.;
- Elmquist, William F.;
- Gampa, Gautham;
- Vondrak, Jessica;
- Aldrich, Jessica;
- Cuyugan, Lori;
- Adkins, Jonathan;
- De Luca, Valerie;
- Tibes, Raoul;
- Borad, Mitesh J.;
- Marceau, Katie;
- Myers, Thomas J.;
- Paradiso, Linda J.;
- Liang, Winnie S.;
- Korn, Ronald L.;
- Cridebring, Derek;
- Von Hoff, Daniel D.;
- Carpten, John D.
Publication type:
Article
Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic.
Published in:
PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100244
By:
- Weiss, Glen J.;
- Ganeshan, Balaji;
- Miles, Kenneth A.;
- Campbell, David H.;
- Cheung, Philip Y.;
- Frank, Samuel;
- Korn, Ronald L.
Publication type:
Article
Clonal Evolution of a Case of Treatment Refractory Maxillary Sinus Carcinoma.
Published in:
PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045614
By:
- Arora, Shilpi;
- Korn, Ronald L.;
- Lenkiewicz, Elizabeth;
- Cherni, Irene;
- Beach, Thomas G.;
- Hostetter, Galen;
- Barrett, Michael T.;
- Weiss, Glen J.;
- Eaves, Connie J.
Publication type:
Article
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
Published in:
Scientific Reports, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41598-024-62470-9
By:
- Arias-Lorza, Andrés M.;
- Costello, James R.;
- Hingorani, Sunil R.;
- Von Hoff, Daniel D.;
- Korn, Ronald L.;
- Raghunand, Natarajan
Publication type:
Article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2018, v. 118, n. 2, p. 153, doi. 10.1038/bjc.2017.327
By:
- Infante, Jeffrey R;
- Korn, Ronald L;
- Rosen, Lee S;
- LoRusso, Patricia;
- Dychter, Samuel S;
- Zhu, Joy;
- Maneval, Daniel C;
- Jiang, Ping;
- Shepard, H Michael;
- Frost, Gregory;
- Von Hoff, Daniel D;
- Borad, Mitesh J;
- Ramanathan, Ramesh K
Publication type:
Article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
Published in:
2018
By:
- Infante, Jeffrey R;
- Korn, Ronald L;
- Rosen, Lee S;
- LoRusso, Patricia;
- Dychter, Samuel S;
- Zhu, Joy;
- Maneval, Daniel C;
- Jiang, Ping;
- Shepard, H Michael;
- Frost, Gregory;
- Von Hoff, Daniel D;
- Borad, Mitesh J;
- Ramanathan, Ramesh K
Publication type:
corrected article
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
Published in:
2017
By:
- Infante, Jeffrey R;
- Korn, Ronald L;
- Rosen, Lee S;
- LoRusso, Patricia;
- Dychter, Samuel S;
- Zhu, Joy;
- Maneval, Daniel C;
- Jiang, Ping;
- Shepard, H Michael;
- Frost, Gregory;
- Von Hoff, Daniel D;
- Borad, Mitesh J;
- Ramanathan, Ramesh K
Publication type:
journal article
Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71246-w
By:
- Lorza, Andres M. Arias;
- Ravi, Harshan;
- Philip, Rohit C.;
- Galons, Jean-Philippe;
- Trouard, Theodore P.;
- Parra, Nestor A.;
- Von Hoff, Daniel D.;
- Read, William L.;
- Tibes, Raoul;
- Korn, Ronald L.;
- Raghunand, Natarajan
Publication type:
Article
MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.
Published in:
International Journal of Cancer, 2011, v. 129, n. 11, p. 2621, doi. 10.1002/ijc.25939
By:
- Arora, Shilpi;
- Ranade, Aarati R.;
- Tran, Nhan L.;
- Nasser, Sara;
- Sridhar, Shravan;
- Korn, Ronald L.;
- Ross, Julianna T.D;
- Dhruv, Harshil;
- Foss, Kristen M.;
- Sibenaller, Zita;
- Ryken, Timothy;
- Gotway, Michael B.;
- Kim, Seungchan;
- Weiss, Glen J.
Publication type:
Article
Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors.
Published in:
Cancer (0008543X), 2012, v. 118, n. 21, p. 5310, doi. 10.1002/cncr.27532
By:
- Weiss, Glen J.;
- Korn, Ronald L.
Publication type:
Article
<sup>18</sup>F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer.
Published in:
2017
By:
- Korn, Ronald L.;
- Von Hoff, Daniel D.;
- Borad, Mitesh J.;
- Renschler, Markus F.;
- McGovern, Desmond;
- Bay, R. Curtis;
- Ramanathan, Ramesh K.;
- Curtis Bay, R
Publication type:
journal article

Found: 12